Leading reasons for accepting the Sinovac COVID-19 vaccine in Indonesia 2020

Published by Hanadian Nurhayati-Wolff, Apr 30, 2021
A survey on vaccinations against coronavirus (COVID-19) conducted in Indonesia in 2020 found that 29 percent of respondents trusted the government's choice of the Sinovac vaccine. Indonesia began its mass coronavirus (COVID-19) vaccination campaign in January 2021 and has approved the Chinese Sinovac vaccine for emergency purposes.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Most common reasons for accepting the Sinovac coronavirus (COVID-19) vaccine in Indonesia as of December 2020

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

December 2020

Region

Indonesia

Survey time period

December 2020

Number of respondents

4,398 respondents

Method of interview

Online survey

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Coronavirus (COVID-19): vaccines and vaccination campaign "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Coronavirus (COVID-19): vaccines and vaccination campaign

Pandemic situation

5

Search for vaccines

7

Leading products and companies

7

Vaccination campaign

5

Distribution inequality

5

Vaccination approval and willingness

8

Further related statistics

14

Further Content: You might find this interesting as well

Statistics

Topics

Sputnik V COVID-19 vaccineAstraZenecaCoronavirus disease (COVID-19) pandemicCoronavirus (COVID-19) vaccines and treatmentsCoronavirus (COVID-19) in Russia
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.